A Wexford-based biopharmaceutical company announced it is actively considering the possibility of acquiring a cell therapy platform and has obtained the exclusive rights to do so as it conducts a due diligence process.
Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP) said that the potential acquisition of VyGen-Bio Inc., based in Tampa, Florida, would strengthen the Pittsburgh company's oncology product pipeline as it would contain exclusive ownership rights to VyGen-Bio's GEAR Platform and related…
